spacer
home > ebr > spring 2002 > bioinformatics education - skills shortage or fundamental shift in skill creation and demand?
PUBLICATIONS
European Biopharmaceutical Review

Bioinformatics Education - Skills Shortage or Fundamental Shift in Skill Creation and Demand?

Paradigm Shift in Life Science Skills

There is a wide perception that the rapid growth in the amount and diversity of digitalised biological data is exceeding the available supply of skills to analyse, process and manage it. In this view, the problem is a skills gap or shortage (1,2). However, it could be argued that there is a far more fundamental issue at stake here. A paradigm shift in the nature of biological sciences is beginning to bear fruit in a new range of technologies across many industries - a parallel technology paradigm shift. From this perspective, the issue of human skills and capabilities is not simply one of supply bottlenecks (due to insufficient existing skills) but one of a top-to-bottom redisciplining of biology and the creation of new patterns of interdisciplinarity. In a recent report for the UK Department of Trade and Industry, the UK bioinformatics scene was analysed with respect to its recent developments and future prospects, through a focus on interactions between industry and academia, knowledge transfer, intellectual property rights (IPR) regimes and public versus private funding (3). It was shown that bioinformatic skills and capabilities are developed in both educational and commercial organisations, and that there are flows between them of both knowledge/information and human skills.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Erich Bornberg-Bauer of UMBER Bioinformatics, School of Biological Sciences, and Mark Harvey and Andrew McMeekin of CRIC ESRC Centre for Research on Innovation and Competition, all at the University of Manchester, UK
Dr Erich Bornberg-Bauer is a Senior Lecturer at the School of Biological Sciences, University of Manchester, UK. He has a background in mathematics and biochemistry and worked as a Postdoc at the German Cancer Research Centre and as a Project Manager at the EML (an SME), both in Heidelberg, Germany. His main research interests lie in molecular evolution and computation of biochemical pathways.
Dr Mark Harvey has been a Senior Research Fellow at the ESRC Centre for Research on Innovation and Competition (CRIC) since 1997. His research has focused on innovation and comparative economic institutions, including agrifood, food retailing, and the development of GMOs for commercial markets. He has also undertaken research on skill formation and labour markets in different European economies, and is involved in two major European research networks, including one on trust in food. His current research now includes comparative analysis of the development of biotechnology and genomics in the agrifood sector, and bioinformatics in Europe, the US and South America.
Dr Andrew McMeekin has been a Research Fellow at the ESRC Centre for Research on Innovation and Competition (CRIC) since 1997. He previously worked and studied at Manchester School of Management, UMIST, and the Science Policy Research Unit (SPRU) at Sussex University, UK. His research has focused on social and economic aspects of the organisation and management of technological innovation in firms, and on government science and technology policy. This research has involved interaction with technical directors from many of the UK's largest high technology firms, policy makers and a number of non-governmental organisations. His current research is on developments in biotechnology, genomics and bioinformatics, with a particular focus on the agrifood sector.


spacer
Dr Erich Bornberg-Bauer
spacer
spacer
spacer
Dr Mark Harvey
spacer
spacer
spacer
Dr Andrew McMeekin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge boom in Korean Pharma reported at CPhI Korea

Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI Pharma Index[1], Korea has seen a rapid growth in its international reputation (seeing its ‘overall competitiveness’ rise 14% in the last two years), which is now translating into a sizable growth in the market and at the event.
More info >>

White Papers

Sterile Vials Made of Tubular Glass

Gerresheimer AG

Gx® RTF vials powered by Ompi EZ-fill® enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and ready-to-fill processing for our pharma and biotech customers.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement